Directed by Cécilia Flores, PhD, the laboratory investigates brain abnormalities at the cellular and molecular level contributing to behaviours associated with schizophrenia and addiction.

The Psychotic Disorders Program at the Douglas Institute provides services to adults aged 18 to 65 with schizophrenia or other forms of psychoses, with the exception of the Prevention and Early Intervention Program for Psychoses (PEPP-Montréal), which is designed for people aged 14 to 30.

Out-patient services are made up of interdisciplinary teams that offer assertive community treatment (ACT) and variable community follow-up (SIV for Suivi d’intensité variable)for people suffering from psychotic disorders.

The Prevention and Early Intervention Program for Psychosis (PEPP-Montréal) is a program for young people who are experiencing an untreated first episode of psychosis.

A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Clinic for Assessment of Youth at Risk (CAYR) is a sub-program of PEPP-Montréal and accepts youth between 14 and 30 years of age who have never experienced a psychotic episode but who show signs of increased risk for developing psychosis.

Hospitalization and transition services covering different levels of structured support, from a locked unit to community transition settings. Based on a recovery model, the program aims to improve autonomy and to reintegrate and maintain people in the

Causes and treatments of psychosis, a syndrome associated with a variety of mental, behavioural and emotional problems.

Four major themes cover the research activities in Rémi Quirion's laboratory.